Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy
Authors
Keywords
-
Journal
Viruses-Basel
Volume 10, Issue 2, Pages 90
Publisher
MDPI AG
Online
2018-02-24
DOI
10.3390/v10020090
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zika virus has oncolytic activity against glioblastoma stem cells
- (2017) Zhe Zhu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus
- (2017) Sébastien A. Felt et al. JOURNAL OF VIROLOGY
- Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer
- (2017) Shruthi Naik et al. MOLECULAR CANCER THERAPEUTICS
- Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity
- (2017) David Olagnier et al. MOLECULAR THERAPY
- Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers
- (2017) Dylan J. Fehl et al. VIRUS RESEARCH
- Smac mimetics and oncolytic viruses synergize in driving anticancer T-cell responses through complementary mechanisms
- (2017) Dae-Sun Kim et al. Nature Communications
- Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV
- (2017) Lauro Velazquez-Salinas et al. Human Gene Therapy Clinical Development
- Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models
- (2017) Fabrice Le Boeuf et al. Molecular Therapy-Oncolytics
- Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
- (2017) Dina Kleinlützum et al. Frontiers in Oncology
- VEGF-D-enhanced lymph node metastasis of ovarian cancer is reversed by vesicular stomatitis virus matrix protein
- (2016) XIAORONG QI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Privileged Antigen Presentation in Splenic B Cell Follicles Maximizes T Cell Responses in Prime-Boost Vaccination
- (2016) Byram W. Bridle et al. JOURNAL OF IMMUNOLOGY
- Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS
- (2016) Lianwen Zhang et al. Human Gene Therapy Clinical Development
- Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity
- (2016) Marie-Claude Bourgeois-Daigneault et al. Molecular Therapy-Oncolytics
- Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
- (2015) W. Shen et al. BLOOD
- Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia
- (2015) Dillon Betancourt et al. JOURNAL OF VIROLOGY
- Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis
- (2015) Marlena M. Westcott et al. JOURNAL OF VIROLOGY
- Oncolytic viruses: a new class of immunotherapy drugs
- (2015) Howard L. Kaufman et al. NATURE REVIEWS DRUG DISCOVERY
- Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
- (2014) A. Muik et al. CANCER RESEARCH
- PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
- (2013) M. Z. Tesfay et al. JOURNAL OF VIROLOGY
- Characteristics of Oncolytic Vesicular Stomatitis Virus Displaying Tumor-Targeting Ligands
- (2013) A. Ammayappan et al. JOURNAL OF VIROLOGY
- Neuroattenuation of Vesicular Stomatitis Virus through Picornaviral Internal Ribosome Entry Sites
- (2013) A. Ammayappan et al. JOURNAL OF VIROLOGY
- New viruses for cancer therapy: meeting clinical needs
- (2013) Tanner S. Miest et al. NATURE REVIEWS MICROBIOLOGY
- Treatment with targeted vesicular stomatitis virus generates therapeutic multifunctional anti-tumor memory CD4 T cells
- (2012) Y Gao et al. CANCER GENE THERAPY
- Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
- (2012) Alexander Muik et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Highly Attenuated Recombinant Vesicular Stomatitis Virus VSV-12'GFP Displays Immunogenic and Oncolytic Activity
- (2012) A. N. van den Pol et al. JOURNAL OF VIROLOGY
- A ribosome-specialized translation initiation pathway is required for cap-dependent translation of vesicular stomatitis virus mRNAs
- (2012) A. S.-Y. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complexes of Vesicular Stomatitis Virus Matrix Protein with Host Rae1 and Nup98 Involved in Inhibition of Host Transcription
- (2012) Karishma R. Rajani et al. PLoS Pathogens
- Engineering fibrinogen-binding VSV-G envelope for spatially- and cell-controlled lentivirus delivery through fibrin hydrogels
- (2011) Roshan M. Padmashali et al. BIOMATERIALS
- Virus-Tumor Interactome Screen Reveals ER Stress Response Can Reprogram Resistant Cancers for Oncolytic Virus-Triggered Caspase-2 Cell Death
- (2011) Douglas J. Mahoney et al. CANCER CELL
- Enhancing VSV oncolytic activity with an improved cytosine deaminase suicide gene strategy
- (2011) S Leveille et al. CANCER GENE THERAPY
- Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity
- (2011) K B Stephenson et al. CANCER GENE THERAPY
- Vesicular Stomatitis Virus Expressing Tumor Suppressor p53 Is a Highly Attenuated, Potent Oncolytic Agent
- (2011) J. F. Heiber et al. JOURNAL OF VIROLOGY
- Vesicular Stomatitis Virus Oncolytic Treatment Interferes with Tumor-Associated Dendritic Cell Functions and Abrogates Tumor Antigen Presentation
- (2011) S. Leveille et al. JOURNAL OF VIROLOGY
- Mutations in the Glycoprotein of Vesicular Stomatitis Virus Affect Cytopathogenicity: Potential for Oncolytic Virotherapy
- (2011) V. Janelle et al. JOURNAL OF VIROLOGY
- Targeting Tumor Vasculature With an Oncolytic Virus
- (2011) Caroline J Breitbach et al. MOLECULAR THERAPY
- Involvement of Noxa in mediating cellular ER stress responses to lytic virus infection
- (2011) Shaun Rosebeck et al. VIROLOGY
- Susceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus
- (2010) M Ahmed et al. CANCER GENE THERAPY
- Type III IFN Interleukin-28 Mediates the Antitumor Efficacy of Oncolytic Virus VSV in Immune-Competent Mouse Models of Cancer
- (2010) Phonphimon Wongthida et al. CANCER RESEARCH
- VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 Signaling
- (2010) Phonphimon Wongthida et al. MOLECULAR THERAPY
- Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma
- (2009) F Galivo et al. GENE THERAPY
- VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1
- (2009) P Schache et al. GENE THERAPY
- Interference of CD40L-Mediated Tumor Immunotherapy by Oncolytic Vesicular Stomatitis Virus
- (2009) Feorillo Galivo et al. HUMAN GENE THERAPY
- Down-regulation of type I interferon receptor sensitizes bladder cancer cells to vesicular stomatitis virus-induced cell death
- (2009) Kai-xin Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Oncolytic virus therapy for prostate cancer
- (2009) Hiroshi Fukuhara et al. INTERNATIONAL JOURNAL OF UROLOGY
- Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells
- (2009) G. Wollmann et al. JOURNAL OF VIROLOGY
- Attenuation of Vesicular Stomatitis Virus Encephalitis through MicroRNA Targeting
- (2009) E. J. Kelly et al. JOURNAL OF VIROLOGY
- Recombinant Vesicular Stomatitis Virus Transduction of Dendritic Cells Enhances Their Ability to Prime Innate and Adaptive Antitumor Immunity
- (2009) Jeanette E Boudreau et al. MOLECULAR THERAPY
- IFN-β-Induced Alteration of VSV Protein Phosphorylation in Neuronal Cells
- (2009) Paul M. D'agostino et al. VIRAL IMMUNOLOGY
- Enhanced oncolytic potency of vesicular stomatitis virus through vector-mediated inhibition of NK and NKT cells
- (2008) J Altomonte et al. CANCER GENE THERAPY
- Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors
- (2008) Y Gao et al. CANCER GENE THERAPY
- rVSV(MΔ51)-M3 Is an Effective and Safe Oncolytic Virus for Cancer Therapy
- (2008) Lan Wu et al. HUMAN GENE THERAPY
- A let-7 MicroRNA-sensitive Vesicular Stomatitis Virus Demonstrates Tumor-specific Replication
- (2008) Robert E Edge et al. MOLECULAR THERAPY
- Exponential Enhancement of Oncolytic Vesicular Stomatitis Virus Potency by Vector-mediated Suppression of Inflammatory Responses In Vivo
- (2007) Jennifer Altomonte et al. MOLECULAR THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search